(Q41580982)

English

Targeting chemosensitizing doses of toremifene based on protein binding

scientific article published on January 1993

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

Targeting chemosensitizing doses of toremifene based on protein binding (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

author name string

G T Wurz

1

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

V D Emshoff

2

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

M W DeGregorio

3

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

V J Wiebe

4

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

publication date

1 January 1993

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

412-414

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

Reversal of multidrug resistance by non-antitumor anthracycline analogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triphenylethylenes: a new class of protein kinase C inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uptake and metabolism of daunorubicin by human leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of toremifene to human serum proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials of agents that reverse multidrug-resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug resistance: P-glycoprotein and its allies--the elusive foes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toremifene and its metabolites enhance doxorubicin accumulation in estrogen receptor negative multidrug resistant human breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8431976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00686157

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41580982&oldid=2204637596"